Utah Medical Products Inc $UTMD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Midvale, UT
- Fiscal year end
- December 31
- Shares outstanding
- 3,183,818 [10-Q 2026-08-12]
What the company doesAI summary of filing
Utah Medical Products, Inc. manufactures and sells medical devices focused on patient safety and improved clinical outcomes, primarily for use in neonatal intensive care units, labor and delivery departments, women's health centers, and outpatient clinics. The company is revenue-generating, deriving income from direct sales to hospitals and clinical end-users in the United States and internationally, sales through medical device distributors, and original equipment manufacturer (OEM) work producing components and finished devices for other companies. Domestically, UTMD sells through its own sales force and designated stocking distributors; outside the U.S., it distributes directly to end-users in Canada, the UK, France, Ireland, Australia, and New Zealand, and through approximately 200 independent regional distributors in other countries. Products acquired through acquisitions comprised 57% of consolidated 2025 sales. [10-K 2026-03-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $17.25M | $5.29M | $4.49M | $87.53M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $38.52M | $11.29M | $14.69M | $85.76M | [10-K 2026-03-27] |
| FY ended Dec 2024 | $40.90M | $13.87M | $14.83M | $82.98M | [10-K 2026-03-27] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-11 | 3,391,620 | [10-Q 2024-11-12] |
| 2025-03-25 | 3,281,816 | [10-K 2025-03-26] |
| 2025-05-12 | 3,248,210 | [10-Q 2025-05-15] |
| 2025-08-11 | 3,205,723 | [10-Q 2025-08-12] |
| 2025-11-10 | 3,203,672 | [10-Q 2025-11-14] |
| 2026-03-26 | 3,185,025 | [10-K 2026-03-27] |
| 2026-05-11 | 3,184,025 | [10-Q 2026-05-12] |
| 2026-08-11 | 3,183,818 | [10-Q 2026-08-12] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-29 | Richins Paul O | other | 150 | $73.07 | [4 2026-07-01] |
| 2026-05-28 | Koopman Brian | other | 50 | $66.27 | [4 2026-05-29] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-31 | 8-K | Regulation FD disclosure |
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-07-23 | 8-K | Results of operations |
| 2026-05-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-12 | 10-Q | Quarterly report |
| 2026-05-04 | 8-K | Shareholder vote results |
| 2026-04-23 | 8-K | Results of operations |
| 2026-04-02 | DEF 14A | Proxy statement |
| 2026-03-27 | 10-K | Annual report |
| 2026-03-27 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $UTMD
Email me when Utah Medical Products Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.